(NASDAQ: CRBU) Caribou Biosciences's forecast annual revenue growth rate of 7.68% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 97.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.77%.
Caribou Biosciences's revenue in 2025 is $9,295,000.On average, 9 Wall Street analysts forecast CRBU's revenue for 2025 to be $928,324,553, with the lowest CRBU revenue forecast at $844,390,255, and the highest CRBU revenue forecast at $981,414,399. On average, 9 Wall Street analysts forecast CRBU's revenue for 2026 to be $961,973,047, with the lowest CRBU revenue forecast at $852,802,379, and the highest CRBU revenue forecast at $1,128,626,559.
In 2027, CRBU is forecast to generate $1,107,689,718 in revenue, with the lowest revenue forecast at $861,307,970 and the highest revenue forecast at $1,472,121,599.